Matrix metalloproteinase-2 expression and promoter/enhancer activity in skeletal muscle atrophy

Journal of Orthopaedic Research

Volumn 26, Issue 3, 2008, Pages 357-363

  Skittone, Laura K ^a   Liu, Xuhui ^b   Tseng, Alice ^a   Kim, Hubert T ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Achilles tendon; Disuse; Matrix metalloproteinase 2; Muscular atrophy; Transgenic mice

Indexed keywords

GELATINASE A; MESSENGER RNA; PROTEIN C JUN; TRANSCRIPTION FACTOR FOSB; PROTEIN C FOS;

ACHILLES TENDON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BLOOD VESSEL; CELL NUCLEUS; FASCIA; GENETICS; INNERVATION; METABOLISM; MOUSE STRAIN; MUSCLE CELL; NERVOUS TISSUE; ORGAN SIZE; PATHOLOGY; RAT; SKELETAL MUSCLE; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; CELL NUCLEUS; ENHANCER ELEMENTS (GENETICS); EXTRACELLULAR MATRIX; FASCIA; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NERVE TISSUE; ORGAN SIZE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RNA, MESSENGER;

EID: 40949126161     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20513     Document Type: Article

References (20)

1. Giannelli G, De Marzo A, Marinosci F, et al. 2005. Matrix metalloproteinase imbalance in muscle disuse atrophy. Histol Histopathol 20:99-106.
2. Choi HR, Kondo S, Hirose K, et al. 2002. Expression and enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in rabbits. J Orthop Res 20:927-933.
3. Reznick AZ, Menashe O, Bar-Shai M, et al. 2003. Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats. Muscle Nerve 27:51-59.
4. Bar-Shai M, Carmeli E, Coleman R, et al. 2005. The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old rats. Mech Ageing Dev 126:289-297.
5. Carmeli E, Haimovitch TG, Nemcovsky CE. 2006. Expression of matrix metalloproteinase 2 and heat shock protein-72 in immobilized muscle in rats. J Musculoskelet Neuronal Interact 6:96-102.
6. Westermarck J, Kahari VM. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792.
7. Nagase H, Woessner JF Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
8. Bendeck MP. 2002. Matrix metalloproteinases. Are they antiatherogenic but proaneurysmal? Circ Res 90:836-837.
9. Vincenti MP, Brinckerhoff CE. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4:157-164.
10. Kuzuya M, Iguchi A. 2003. Role of matrix metalloprotei-nases in vascular remodeling. J Atheroscler Thromb 10: 275-282.
11. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr. 2004. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 9:53-61.
12. Kerrigan JJ, Mansell JP, Sandy JR. 2000. Matrix turnover. J Orthodonitics 27:227-233.
13. Kovanen V. 2002. Intramuscular extracellular matrix: complex environment of muscle cells. Exerc Sport Sci Rev 30:20-25.
14. Benedikt GH, Schoser CA, Blottner D. 1999. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in dener-vated human muscle. Clin Neurosci 10:2795-2797.
15. Yu AE, Murphy AN, Stetler-Stevenson WG. 1998. 2-kDa gelatinase (gelatinase A): structure, activation, regulation and substrate specificity. In: Parks WC, Mecham RP, editors. Matrix metalloproteinase. Sam Diego, CA: Academic Press; pp 85-113.
16. McLachlan E. 1981. Rapid atrophy of mouse soleus muscles after tenotomy depends on an intact innervation. Neurosci Lett 25:269-274.
17. Roach DM, Fitridge RA, Laws PE, et al. 2002. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vase Endovasc Surg 23:260-269.
18. Dahi S, Lee JG, Lovett DH, et al. 2005. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin. J Vase Surg 42:539-545.
19. Alfonso-Jaume MA, Bergman MR, Mahimkar R, et al. 2006. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am J Physiol Heart Circ Physiol 291:H1838-H1846.
20. Lee JG, Dahi S, Mahimkar R, et al. 2005. Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia. Proc Natl Acad Sci USA 102:16345-16350.